Subscribe to RSS - home infusion

home infusion

NHIA honors Reps. Engel, Tiberi


WASHINGTON – The National Home Infusion Association has named Rep. Eliot Engel, D-N.Y., as the recipient of its Congressional Leadership Award.

NHIA responds to OIG report on infusion payments


ALEXANDRIA, Va. – A recent Office of Inspector General report on payment for Part B DME infusion drugs is far too narrow to be the basis for new policy, according to the National Home Infusion Association.

BioScrip, Home Solutions tweak deal


DENVER – The price tag for BioScrip’s acquisition of Home Solutions has dropped from $85 million to $75 million, according to news reports.

Short takes: PharMerica, HaysMed


PharMerica Corp., a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, has announced that David Froesel, executive vice president, CFO and treasurer, intends to retire.

Close monitoring of patients ensures outcomes, savings


ORLANDO, Fla. ­–­ Close monitoring of hemophilia patients ensures bleed rate stays low and the patients can be managed with less factor VIII, according to a study by Option Care being presented at the World Federation of Hemophilia 2016 World Congress meeting today.

BioScrip makes buy, announces public offering


DENVER – BioScrip, a provider of infusion and homecare management solutions, has entered into an agreement to buy the business of HS Infusion Holdings.

InfuSystem buys infusion pump assets


MADISON HEIGHTS, Mich. – A subsidiary of InfuSystem Holdings, a national provider of infusion pumps and related services in the U.S. and Canada, has reached an agreement to acquire the infusion pump assets of Philadelphia-based InfusAID.

Court orders PharMerica to pay $48.5M tab


LOUISVILLE, Ky. – A circuit court judge has told PharMerica Corp., a national provider with 17 specialty home infusion pharmacies, to honor outstanding invoices from AmerisourceBergen Drug Corp. for about $48.5 million.

Home infusion market refuses to stand still


YARMOUTH, Maine – When it comes to mergers and acquisitions in the home infusion space, analysts report seeing a “blurring of the lines” among its different segments.